We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
Conclusions: Although pseudomyxomaperitonei is associated with borderline and well-differentiated tumors, recurrence is common and the prognosis after recurrence is guarded.
2
Our observation revealed an abundant mucin production with pools of mucin similar to those of pseudomyxomaperitonei and an inflammatory infiltrate with prominent lipid phagocytosis.
3
Methods: Twenty-seven patients with pseudomyxomaperitonei (19 males and 8 females) were enrolled in a phase II clinical trial.
4
Objective: To review the experience at the Massachusetts General and Brigham and Women's Hospitals with 23 women treated for pseudomyxomaperitonei between 1961 and 1991.
5
Aims and background: Pseudomyxomaperitonei is a rare disease characterized by a complete redistribution of mucin within the peritoneal cavity.